Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of psoriasis as a systemic disease: what is the evidence?
Neil J. Korman
British Journal of Dermatology (2019) Vol. 182, Iss. 4, pp. 840-848
Open Access | Times Cited: 391

Showing 1-25 of 391 citing articles:

Neutrophils in Psoriasis
Chih-Chao Chiang, Wei-Jen Cheng, Michal Korinek, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 216
Interleukin-17A and Keratinocytes in Psoriasis
Masutaka Furue, Kazuhisa Furue, Gaku Tsuji, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1275-1275
Open Access | Times Cited: 214
Signaling pathways and targeted therapies for psoriasis
Jia Guo, H. Zhang, Wenrui Lin, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 132
The Cytokine Mediated Molecular Pathophysiology of Psoriasis and Its Clinical Implications
Rohan Singh, Sindhuja Koppu, Patrick O. Perche, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12793-12793
Open Access | Times Cited: 110
Gut–Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis
Angel Yun-Kuan Thye, Yi-Rou Bah, Jodi Woan‐Fei Law, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1037-1037
Open Access | Times Cited: 92
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Yuxiong Jiang, Youdong Chen, Qian Yu, et al.
BioDrugs (2023) Vol. 37, Iss. 1, pp. 35-55
Open Access | Times Cited: 56
Disease modification in inflammatory skin disorders: opportunities and challenges
Thomas Bieber
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 8, pp. 662-680
Closed Access | Times Cited: 44
Are IL-17 inhibitors superior to IL-23 inhibitors in reducing systemic inflammation in moderate-to-severe plaque psoriasis? A retrospective cohort study
Neslihan Demirel Öğüt, Müge Ayanoğlu, Sema Koç Yıldırım, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access | Times Cited: 2
Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities
Paolo Gisondi, Francesco Bellinato, Giampiero Girolomoni, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 114
Gut Microbiome in Psoriasis: An Updated Review
Mariusz Sikora, Albert Stec, Magdalena Chrabąszcz, et al.
Pathogens (2020) Vol. 9, Iss. 6, pp. 463-463
Open Access | Times Cited: 97
Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches
Anna Campanati, Andrea Marani, Emanuela Martina, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1511-1511
Open Access | Times Cited: 80
Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
Mariya Farooq, Maria Batool, Moon Suk Kim, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 72
Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
April W. Armstrong, Ahmed M. Soliman, Keith A. Betts, et al.
Dermatology and Therapy (2021) Vol. 11, Iss. 3, pp. 885-905
Open Access | Times Cited: 63
Lipid-based nanoparticles for psoriasis treatment: a review on conventional treatments, recent works, and future prospects
Ummu Umaimah Mohd Nordin, Noraini Ahmad, Norazlinaliza Salim, et al.
RSC Advances (2021) Vol. 11, Iss. 46, pp. 29080-29101
Open Access | Times Cited: 60
Psoriasis and Systemic Inflammatory Disorders
Tomoko Tashiro, Yu Sawada
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4457-4457
Open Access | Times Cited: 60
Shared genetic risk factors and causal association between psoriasis and coronary artery disease
Matthew T. Patrick, Qinmengge Li, Rachael Wasikowski, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Targeting CSF-1R represents an effective strategy in modulating inflammatory diseases
Caigui Xiang, Heng Li, Wei Tang
Pharmacological Research (2022) Vol. 187, pp. 106566-106566
Open Access | Times Cited: 50
Single‐cell profiles reveal distinctive immune response in atopic dermatitis in contrast to psoriasis
Bowen Zhang, Lennart M. Roesner, Stephan Traidl, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 439-453
Open Access | Times Cited: 46
Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases
Albert Stec, Mariusz Sikora, Magdalena Maciejewska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3494-3494
Open Access | Times Cited: 34
Long-Term Efficacy and Safety of Risankizumab for Moderate to Severe Psoriasis: A 2-Year Real-Life Retrospective Study
Matteo Megna, Angelo Ruggiero, Teresa Battista, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3233-3233
Open Access | Times Cited: 30
Psoriasis and Vitamin D: A Systematic Review and Meta-Analysis
Elena Formisano, Elisa Proietti, Consuelo Borgarelli, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3387-3387
Open Access | Times Cited: 24
Potential Therapeutic Value of the STING Inhibitors
Shangran Zhang, Runan Zheng, Yanhong Pan, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3127-3127
Open Access | Times Cited: 23
Association between systemic immune-inflammation index and psoriasis: a population-based study
Xiya Zhao, Junqin Li, Xinhua Li
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 16
IL-17A inhibitors alleviate Psoriasis with concomitant restoration of intestinal/skin microbiota homeostasis and altered microbiota function
Huixia Zhao, Lili Shang, Yuting Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Prospective evaluation of cardiovascular risk and mortality in patients with psoriasis: An American population‐based study
Junyan Kan, Qitao Chen, Qiuwei Tao, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 1
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top